Background
==========

qRT-PCR is one of the most sensitive methods for mRNA detection and quantification. The method has also become the preferred method for validating results obtained by other techniques, such as microarray \[[@B1]\]. There are differences among different qRT-PCR assays due to biological and technical variations \[[@B2],[@B3]\]. In order to identify truly gene specific variations it is important to use a suitable normalization method. One of the most commonly used approaches involves relative quantification of target genes against one or more reference genes which are thought to be stably expressed in the examined tissue \[[@B4]\]. There have been a number of reports that demonstrate that the expression levels of putative reference genes vary extensively in different tissues and diseases and thus are unsuitable for normalization purposes \[[@B5]-[@B15]\]. Consequently, each research group has to validate multiple reference genes in their own experimental setup and normalize qRT-PCR data against a few reference genes tested from independent pathways using at least one algorithm. It appears that improvements in methods of identifying reference genes are more important than the identification of the particular reference genes themselves \[[@B16]\].

It has been argued for use of multiple genes in the normalization of qRT-PCR analysis and several algorithms have been developed \[[@B17]-[@B20]\]. Vandesompele et al., 2002, used the geometric mean of the most stable genes to improve the accuracy of the analysis in a method called geNorm \[[@B19]\]. This method relies on the principle that the expression ratio of two ideal reference genes is identical in all samples regardless of the experimental conditions. For every reference gene geNorm determine the pairwise variation with all other reference genes. The average pairwise variation of a particular gene is defined as the internal control stability measure; M. Genes with the lowest M values are the most stable ones. Another algorithm in which the expressional stability of genes is evaluated is NormFinder \[[@B17]\]. NormFinder estimates the intra-group and the inter-group expression variation. Both of these sources of variation are combined into a stability value. This method can account for heterogeneity of the tested tissue samples. Genes with the lowest stability value have the most stable expression.

Colorectal cancer is among the most frequent malignant diseases worldwide, and is one of the leading causes of cancer-related deaths \[[@B21]\]. The majority of colorectal tumours develop along a well-defined adenoma-carcinoma sequence in which oncogenes are activated and tumour suppressor genes lose their function \[[@B22]\]. Despite a high 5-year survival rate in early colorectal cancer, only 10% of the patients with distant metastases survive after five years \[[@B23]\]. Thus, it is important to elucidate the biology that contributes to this progression, especially those processes that facilitates the switch to invasive and metastatic disease. Biological changes are a result of partly differential gene expression, which can be confirmed by qRT-PCR. It is necessary to validate reference genes in the particular experimental system in order to trust the differential gene expressions which are detected. Previous studies have tried to find universally stable reference genes across several types of cancers, including colon cancer \[[@B24]-[@B26]\]. Recent reports, however, claim that stably expressed genes in one tumour type may not predict stable expression in another tumour type \[[@B12],[@B27]\]. Moreover, results in one tumour type, like colorectal cancer, show stably expressed genes in one experimental in which are different from the stably expressed genes in another experimental setup \[[@B28]-[@B30]\]. Hence, reference genes should be validated and selected in every experiment in any tissue type. Recently, it has been suggested that the focus should be on introducing and validating novel approach for reference gene identification and standardizing experimental setup rather than giving general suggestions for different tissues \[[@B16]\]. Applying TaqMan Low Density Array (TLDA) to examining reference genes is a step towards a more standardized experimental setup. TLDA was evaluated in colorectal cancer by Lü et al., 2008, as a roughly robust and labour-saving method for gene quantification compared with routine qRT-PCR \[[@B31]\]. Well-designed TaqMan probes require little optimization, and TLDA allows simultaneously real-time detection of many gene products in several samples offering higher through put than established single array method \[[@B31],[@B32]\]. Hence, in the present study we used TLDA to find potential reference genes for data normalization in qRT-PCR experiments in metastatic and non-metastatic colon cancer patients. The gene expression of 16 commonly used reference genes in tumour tissue and individual-matched normal mucosa of metastatic and non-metastatic colon cancer patients were analyzed and the expression stability was determined and compared using geNorm and NormFinder.

Methods
=======

Patients and tissue specimens
-----------------------------

RNAlater-stored tumour tissue samples and individual-matched normal mucosa were obtained from 38 patients with colonic adenocarcinoma who underwent resection at Akershus University Hospital Trust between 2004 and 2009. The dissected tissue samples were collected in the operating room and stored immediately in approximately five volumes of RNAlater (Ambion Inc., Austin TX, USA) and frozen at -80°C. Eighteen patients with non-metastatic disease, Dukes B (with a minimum of 12 negative lymph nodes) where no metastases occurred during 5 years follow up, and 20 patients originally staged as Duke C who displayed distant metastases during a 5 year follow-up (Duke C) or patients classified as Dukes D were included in the study. There were 22 women and 16 men with a mean age of 69 +/- 14 years (range 29-92) at surgery. Three sectioned pieces of the tumour samples were made. The central piece was further processed for RNA isolation, while the two end pieces were fixed in formalin and embedded in paraffin (FFPE). Four μm sections of FFPE samples were stained with Hagens Hematoxylin and examined by a pathologist for determination of percentage tumour cells. To avoid bias from necrosis or minimal tumour representation we included tumour tissue samples with more than 70% tumour cells.

mRNA isolation
--------------

Total RNA isolation was performed using the method of Wei and Khan, 2002, \[[@B33]\] modified according to T. Lüders (unpublished work) to also include miRNA for further analyses. Approximately 60 mg frozen tissue was homogenized in TriReagent (Ambion) using Mixer Mill MM301 (Retch) for 2 × 2 min at 30 Hz. After phase-separation with chloroform, the aqueous phase (containing RNA) was mixed with 1.5 volumes 100% ethanol and transferred to an RNeasy Mini spin column (Qiagen). Further processing was performed following the manufacturer\'s protocol. A DNase treatment was included in the procedure. RNA was eluted in 60 μl RNase-free water and stored at -80°C. The concentration of each RNA sample was obtained from A~260~measurements using the NanoDrop 2000 (Thermo Fischer Scientific Inc.). The RNA integrity number (RIN) was tested by using the Agilent 2100 Bioanalyzer (Agilent Technologies).

cDNA synthesis
--------------

Complementary DNAs (cDNAs) were produced from 1 μg RNA of each sample using the High Capacity RNA-to-cDNA Master Mix (Applied Biosystems) according to the manufacturer\'s instructions. The following thermal cycler conditions were used: 5 min at 25°C, 30 min at 42°C and 5 min at 85°C. Three random RNA samples were additionally run in the absence of reverse transcriptase enzyme to assess the degree of contaminating genomic DNA. Real-time PCR with genomic DNA specific assay revealed that RNA was free of genomic DNA (data not shown).

TLDA design and preparation
---------------------------

TaqMan Endogenous Control Assays (Applied Biosystems) are 384-well microfluidic cards containing 16 preoptimized human TaqMan Gene Expression Assays commonly used as endogenous controls and genes that exhibit minimal differential expression across different tissues (Table [1](#T1){ref-type="table"}). The assay was performed in triplicates. 50 μl cDNA (1 μg mRNA) was used as a template. Matched samples from 4 patients where loaded on each card. NTC (no template control) was added in one loading port. PCR amplification was performed using the ABI Prism 7900 HT Real Time PCR System (Perkin-Elmer Applied Biosystems, Foster City, California, USA). Thermal cycling conditions were used as follows: 2 min at 50°C, 10 min at 94.5°C, 30 sec at 97°C, and 1 min at 59.7°C for 40 cycles.

###### 

Candidate reference genes included in the TaqMan Endogenous Control Assay.

  Gene name                                                       Gene symbol   Assay ID        Size (bp)   Function
  --------------------------------------------------------------- ------------- --------------- ----------- --------------------------------------------------------------------------------------------------------------
  18S Ribosomal RNA                                               18S           Hs99999901_s1   187         Part of a ribosomal subunit
  Phosphoglycerate kinase-1                                       PGK1          Hs99999906_m1   75          Key enzyme in glycolysis
  Β-Actin                                                         ACTB          Hs99999903_m1   171         Cytoskeletal structural protein
  Polymerase (RNA) II polypeptide A                               POLR2A        Hs00172187_m1   61          Catalyzes the RNA synthesis from DNA
  Beta-2-microglobulin                                            B2M           Hs99999907_m1   75          Beta-chain of major histocompatibility complex class I molecules
  Peptidyl-prolyl isomerase/cyclophilin A                         PPIA          Hs99999904_m1   98          Catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides, accelerating folding
  Glyceraldehyd-3-phosphate dehydrogenase                         GAPDH         Hs99999905_m1   122         Dehydrogenase, oxidoreductase in glycolysis and gluconeogenesis
  Acidic ribosomal phosphoprotein P0                              RPLP0         Hs99999902_m1   105         Ribosome biogenesis and assembly
  Β-Glucuronidase                                                 GUSB          Hs99999908_m1   81          Glycoprotein, degradation of dermatan and keratin sulfates
  Transcription factor IID, TATA box binding protein              TBP           Hs99999910_m1   127         TATA binding protein, general RNA polymerase II transcription factor
  Hydromethylbilane synthase                                      HMBS          Hs00609297_m1   64          Heme synthesis, porphyrin metabolism
  Transferrin receptor (p90, CD71)                                TFRC          Hs99999911_m1   105         Cellular uptake of iron
  Hypoxanthine-phosphoribosyl-transferase 1                       HPRT1         Hs99999909_m1   100         Glycosyltransferase, purine synthesis in salvage pathway
  Ubiquitin C                                                     UBC           Hs00824723_m1   71          Protein degradation
  Importin 8                                                      IPO8          Hs00183533_m1   71          Function in nuclear protein import
  Tyrosine 3 monooxygenase activation protein, zeta polypeptide   YWHAZ         Hs00237047_m1   70          Signal transduction by binding to phosphorylated serine residues on a variety of signalling molecules

TLDA analysis and Statistical analysis
--------------------------------------

RealTime Statminer 3.0 Software (Integromics, Madrid, Spain) was used for implementation of quality controls in addition to calculation of optimal endogenous controls. This program uses the comparative Ct method for relative quantification analysis, and the results are expressed as a fold change of expression levels (DDCt values). The mean value of triplicates was applied for all calculations. Medians were used to replace missing values that occurred due to inconsistencies between replicates rather than from low expression. The detectability threshold was set to 36, meaning failing detectors are those with a Ct greater than or equal to 36. To measure the expressional stability of the candidate endogenous control genes, two commonly used programs were employed: geNorm \[[@B19]\] and NormFinder \[[@B17]\], both of which available in RealTime Statminer. Ct coefficients of variations (CtCV%) were calculated for every reference gene across all samples. All data are expressed as means ± SD. Except from the analyses in RealTime Statminer, all other calculations were performed using SPSS (version 14.0; SPSS, Chicago, IL, USA).

Research Ethics
---------------

This project was approved by the Regional Committee for Medical Research Ethics, Eastern Norway. The Norwegian Social Science Data Service has approved the collection and analysis of data.

Results
=======

RNA quality control
-------------------

mRNAs of 16 potential reference genes were quantified by qRT-PCR using equal amounts of RNA templates from every tissue samples. The integrity of RNA (RIN) was ranged from 7.2 to 10.0, with a mean value of 8.9, which indicates good preservation of the RNA; thus suitable for RNA studies.

Range of expression of candidate endogenous control genes
---------------------------------------------------------

Table [2](#T2){ref-type="table"} presents the mean Ct and SD values obtained across the candidate endogenous control genes in normal and tumour tissue separated into the two groups of patients; non-metastatic and metastatic colon cancer patients. Additional calculations across all patients are shown in Table [3](#T3){ref-type="table"}. Mean Ct values ranged from 8.71 (± 1.31 SD) (18S) across all samples to 26.70 (± 1.69 SD) (TBP). The gene with the lowest standard deviation across all samples was IPO8 which showed an overall SD of 1.28, while the gene with the highest standard deviation across the samples was PGK1 with an overall SD of 2.49. The reference genes displayed a relatively broad range of expression. PGK1 had the widest range of Ct values between 8.35 and 29.83 (mean 21.03 ± 2.49 SD, range of 21.47), while B2M had the narrowest range of Ct values between 15.25 and 23.59 (mean 17.10 ± 1.31 SD, range of 8.34). During the subsequent analyses using Statminer Ct values above 36 are excluded and imputed, because Ct values above this level are not reliable. This quality control will thus influence the Ct ranges.

###### 

Cycle threshold (Ct) values of candidate reference genes divided in the four tissue groups.

  Gene symbol   Non-metastatic colon cancer   Metastatic colon cancer                                                                     
  ------------- ----------------------------- ------------------------- ---- -------- ------- ---- -------- ------- ---- -------- ------- ----
  18S           8,095                         0,546                     18   8,440    1,066   18   8,800    1.066   20   9,408    2,035   20
  ACTB          20,003                        0,765                     18   19,949   1,209   18   20,363   1.209   20   20,578   2,673   20
  B2M           17,050                        0,996                     18   17,041   1,002   18   17,217   1.002   20   17,085   1,632   20
  GAPDH         18,503                        0,722                     18   19,502   1,044   18   19,211   1.044   20   20,145   2,541   20
  GUSB          23,274                        0,375                     18   24,081   0,865   18   23,564   0.865   20   24,060   1,981   20
  HMBS          25,328                        0,736                     18   26,577   0,974   18   25,963   0.974   20   27,030   2,436   20
  HPRT1         22,795                        0,814                     18   24,183   0,750   18   23,320   0.750   20   24,264   1,849   20
  IPO8          24,575                        0,469                     18   25,084   0,780   18   25,099   0.780   20   25,529   2,108   20
  PGK1          20,322                        1,054                     18   21,151   1,012   18   20,996   1.011   20   21,573   3,257   20
  POLR2A        24,007                        0,634                     18   24,508   1,061   18   24,933   1.061   20   25,330   2,590   20
  PPIA          17,081                        0,485                     18   18,241   0,906   18   17,506   0.906   20   18,335   1,724   20
  RPLP0         19,706                        0,637                     18   20,647   0,952   18   20,319   0.952   20   21,081   2,002   20
  TBP           26,157                        0,577                     18   26,860   1,035   18   26,649   1.035   20   27,110   2,797   20
  TFRC          21,774                        0,926                     18   23,334   1,030   18   22,679   1.030   20   23,663   2,303   20
  UBC           21,285                        0,675                     18   21,771   1,046   18   21,532   1.046   20   22,044   2,180   20
  YWHAZ         23,933                        0,723                     18   25,041   1,275   18   24,457   1.275   20   25,401   2,174   20

###### 

Cycle threshold (Ct) values of candidate endogenous control genes across all tissue samples.

  Gene     Mean     ± s.e.m   Standard deviation (SD)   Ct min   Ct max   Ct Range   CtCV%
  -------- -------- --------- ------------------------- -------- -------- ---------- -------
  18S      8.708    0.151     1.314                     6.858    16.932   10.073     14,99
  ACTB     20.236   0.187     1.630                     17.979   31.018   13.039     8,10
  B2M      17.101   0.150     1.306                     15.251   23.587   8.336      7,69
  GAPDH    19.358   0.191     1.661                     17.382   30.403   17.382     8,63
  GUSB     23.748   0.150     1.309                     21.719   32.338   10.619     5,55
  HMBS     26.239   0.186     1.625                     24.315   36.823   12.508     6,23
  HPRT1    23.649   0.164     1.429                     21.852   31.617   9.765      6,04
  IPO8     25.085   0.146     1.276                     23.749   33.903   10.154     5,12
  PGK1     21.025   0.285     2.487                     8.354    29.829   21.474     10,35
  POLR2A   24.717   0.184     1.606                     20.827   34.874   14.047     6,54
  PPIA     17.978   0.150     1.305                     15.980   25.150   9.170      7,34
  RPLP0    20.452   0.162     1.413                     18.682   29.171   10.489     6,93
  TBP      26.704   0.194     1.692                     24.858   38.656   13.799     6,38
  TFRC     22.878   0.196     1.711                     19.907   32.261   12.354     7,53
  UBC      21.665   0.163     1.422                     19.475   30.387   10.912     6,60
  YWHAZ    24.720   0.193     1.685                     22.733   32.853   10.120     6,86

*Note*. S.e.m, standard error of mean; CtCV%, Coefficients of variations of candidate reference genes.

Results of validation programs
------------------------------

In order to determine the stability of genes and thus find the best endogenous controls, the data were analysed by geNorm and NormFinder. In these analyses, medians were used to replace missing values because they occurred due to inconsistencies between replicates rather than from low expression. The ranking of the gene expression stability values (M) of the tested endogenous control genes using geNorm is illustrated in Figure [1.A](#F1){ref-type="fig"}. The genes with the highest M, i.e. the least stable genes, gets stepwise excluded until the most stable genes remain. The best two genes are ranked without distinguishing between them. HPRT1 and PPIA were identified as the most stable pair of genes, followed by PGK1 as the third most stable gene. Furthermore, pairwise variation were also calculated using geNorm in order to determine the optimal number of genes required for normalization, Figure [1.B](#F1){ref-type="fig"}. The analysis showed that HPRT1 and PPIA may be sufficient for calculation of the normalization factor and normalization to genes of interest, since the V2/3 value is in this analysis equal to the cut-off value of 0.15 \[[@B19]\]. However, there is a gradual decrease in the pairwise variability plot and thereby an improvement to the normalization factor by adding additional genes to the calculation. Nevertheless, two or three genes would be satisfactory for normalization according to the cut-off value of 0.15. While geNorm uses a pairwise comparison approach, NormFinder first estimates the intra-group and then the inter-group variability of expression of a control gene \[[@B17]\]. In contrast to the geNorm results, NormFinder ranked RPLP0 as the most stable gene, with TBP and GUSB closely behind as second and third, respectively (Figure [2](#F2){ref-type="fig"}). However, using this algorithm the combination of IPO8 and PPIA turned out to have a lower stability score than the most stable single gene. Thus this combination is more suitable for normalizing qPCR. There was considerably closer agreement between the geNorm and Normfinder results on the least stable genes, with the order of 4 out of 5 worst ranking genes being identical; ACTB, 18S, B2M and TFRC. These genes had a stability value more than twice so high (geNorm) and more than 3 times so high (NormFinder) as the best ranking genes.

![**GeNorm analysis of the candidate reference genes**. (A) Average expression stability values of reference genes. Genes are presented in an increasing order of stability from left to right with ACTB being the least stable gene and HPRT1 and PPIA the most stable genes. (B) Determination of optimal number of control genes for normalization. Every bar represents change in normalization accuracy when stepwise adding more reference genes according to ranking in Figure 1. A. To meet the recommended cut-off value of 0.15 two pr three genes would be satisfactory for normalization.](1756-9966-29-144-1){#F1}

![**NormFinder analysis of the candidate reference genes**. Genes are presented in an increasing order of stability from left to right with B2M as the least stable gene and RPLP0 as the most stable gene.](1756-9966-29-144-2){#F2}

Due to different ranking by geNorm and NormFinder of the most stable genes, cycle threshold coefficient of variation (CtCV%) was calculated for each of them. This calculation was recommended by Caradec et al., 2010, in order to validate the NormFinder and geNorm results \[[@B12]\]. According to the CtCV% calculation, one of the NormFinder pairing genes, IPO8, was ranked as the most stable gene with a CtCV% of 5.12%, which supports the NormFinder result. GUSB (5.5%) and HPRT1 (6.04%) are ranked as the second and third respectively, which do not give identical ranking of results obtain using geNorm and NormFinder. The least stable gene using CtCV% was 18S (14.99%), which was according to geNorm and NormFinder ranked as the second and fifth least stable gene, respectively. The summary of the best ranking genes as determined by each of these calculations is illustrated in Table [4](#T4){ref-type="table"}.

###### 

Ranking and best combination of reference genes determined by geNorm, NormFinder and CtCV%.

  Rank                    GeNorm       NormFinder   CtCV%
  ----------------------- ------------ ------------ ---------------
  1                       HPRT1        RPLP0        IPO8 (5.12)
  2                       PPIA         TBP          GUSB (5.55)
  3                       PGK1         GUSB         HPRT1 (6.04)
  4                       RPLP0        POLR2A       HMBS (6.23)
  5                       HMBS         IPO8         TBP (6.38)
  6                       GAPDH        GAPDH        POLR2A (6.54)
  7                       GUSB         PPIA         UBC (6.60)
  8                       IPO8         HPRT1        YWHAZ (6.86)
                                                    
  Best gene/combination   HPRT1/PP1A   IPO8/PPIA    IPO8

Discussion
==========

qRT-PCR has been a breakthrough for the quantification of gene expression in many biological systems. In this study we assume that no single gene stays unaffected under malignant development in colon cancer and therefore identify genes with least variation. We identified two pairs of genes, HPRT1/PPIA and IPO8/PPIA, which may be suitable to normalize gene expression data in studies conducted in metastatic and non-metastatic colon cancer patients. In addition, we found that B2M, ACTB and 18S were unstable in the tissue examined. We propose a standardized approach of finding the most suitable reference gene(s) in every qRT-PCR experiment using TLDA.

Complex signalling pathways have been related to the metastatic progression of colon cancer, hence pathway based gene expression assays, often revealed by qRT-PCR, are significant in cancer biology. Publications dealing with colon cancer have reported gene expression studies in metastatic diseases \[[@B34],[@B35]\]. However, the stability of the reference gene expression in metastatic and non-metastatic primary tumours remains crucial. Ramaswamy et al., 2003, described a gene expression signature that distinguished primary and metastatic adenocarcinomas, indicating that the metastatic potential of human tumours is encoded in the bulk of the primary tumour \[[@B36]\], fully in accordance with modern clonal stem cell theories \[[@B37]\]. Hence, one may presume that the metastatic capacity of the primary tumour will influence commonly chosen reference genes.

The most recent study of reference genes in colon cancer was reported by Kheirelseid et al., 2010, where 64 colorectal tumours and tumour associated normal specimens were examined using qRT-PCR followed by three different statistical algorithms, geNorm, NormFinder and qBaseplus \[[@B30]\]. Kheirelseid et al., 2010, found that the combination of two reference genes, B2M and PPIA, more accurately normalized qRT-PCR data in colorectal cancer. This is in concordance with our findings, where PPIA was one of the two genes identified as the most stable pair. In contrast, B2M was identified as one of the most variable genes in the tissue examined. This disparity may be explained by the difference in patient material since Kheirelseid et al., 2010, included all stages of colon cancer and even included rectum tumour samples. Furthermore the percentage of tumour cells in the samples was not addressed. In the study of Kheirelseid et al., 2010, all three algorithms confirmed the selection of the B2M and PPIA pairing as the best combination of reference genes. In the present study however, the geNorm algorithm differs from the results obtained by NormFinder. According to geNorm HPRT1 and PPIA were the most suitable genes for normalization, but NormFinder suggested IPO8 and PPIA. This discrepancy confirms previous results reported by Caradec et al., 2010, concluding that the evaluation of suitable reference genes dramatically differs according to the statistical method used \[[@B12]\]. Caradec et al., 2010, investigated reference genes in four cell lines treated with four different oxygen concentrations, and observed large variations in gene expression results depending of statistical method used. Thus Caradec et al., 2010, recommended Ct coefficients of variation (CtCV%) calculation for each reference gene for validation of the statistical methods. It is defined as the ratio of the standard deviation to the mean. Genes with low CtCV% value indicate more stable expression of those genes. In the present study, IPO8 was the most stable gene on the basis of CtCV% (5.12%), followed by GUSB (5.55%) and HPRT1 (6.04%) as the second and third most stable gene. Using NormFinder IPO8 was one of the genes which were identified as the most stable pair of genes, which may indicate that the CtCV% verifies the NormFinder results. Nevertheless, PPIA, which was suggested by both geNorm and NormFinder as one of the stable pair of genes, was ranked as the tenth most stable gene with a CtCV% of 7.34%. This may be explained by the low Ct mean of this particular gene (18.0), resulting in a relatively high CtCV% despite a low standard deviation. Another aspect which strengthens the results achieved by NormFinder compared with geNorm is the argument that geNorm lacks robustness compared with NormFinder \[[@B32]\]. Reports show that exclusion of one sample in a specific tissue collection led geNorm to change a suggested reference gene (18S) from being an unstable gene to one of the top ranking stable genes \[[@B32]\]. NormFinder also enables estimation of the variation between sample subgroups, like tumour and normal tissue, thus this algorithm can account for heterogeneity in the tested samples, which may be important considering the heterogeneity of the samples studied.

The optimal normalization will vary with study design. The most suitable reference gene in one medical condition may be regulated in other tissues or diseases. Blanquicett et al., 2002, found that 18S, S9 and GUS were the least regulated genes among 15 putative reference genes when examining tumour and normal colorectal and liver tissues \[[@B28]\]. Furthermore, Dydensborg et al., 2006, identified B2M as the most appropriate gene for normalizing colon carcinomas comparing to normal mucosa when they investigated seven colon adenocarcinomas containing both epithelial and stromal cells \[[@B29]\]. B2M was in this study identified as the least stable gene using NormFinder, and the third most variable gene using geNorm. In the present study where the tumour tissue samples consisted of more than 70% tumour cells some of the stromal cells are excluded. This might explain the discrepancies in the ranking of B2M since tumour tissue is heterogeneous and the fraction of different cells may influence the gene expression results. Moreover, different patient groups, including age and clinical background, may also give dissimilarities across studies. Experimental variations may also influence the gene expression results, though using triplicates in the qRT-PCR analysis as used in this study will diminish this variation.

Single assays qRT-PCR are time- and labour-intensive, and require relatively large amounts of cDNA and PCR reagents in multivariate gene expression studies. TLDA overcome these drawbacks since this technique allows for simultaneously detection of expression of up to 384 genes and requires less template cDNA and PCR reagents than routine qRT-PCR \[[@B1],[@B31],[@B38]-[@B40]\].

Conclusions
===========

In this study we applied TaqMan Low Density Array in order to identify reference genes in metastatic and non-metastatic colon cancer. The genes often used for normalization of gene expression data may be unstable and thus not suited for use, and therefore identifying stable reference genes in the specific experiment is vital for the results. The approach described herein can serve as a template to identify valid reference genes in any disease state. However, the optimal statistical approach to identify the best reference gene(s) remains to be determined. In the present study NormFinder and geNorm identified two different pairs of the most stable genes. The use of CTCV% might be a good validation of the two results. Nevertheless, the expression of target genes should be evaluated and a comparison of the effect of each pair of reference genes should be determined.
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